BQ 788

Drug Profile

BQ 788

Alternative Names: BQ788

Latest Information Update: 17 Sep 2004

Price : $50

At a glance

  • Originator Banyu
  • Class
  • Mechanism of Action Endothelin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hypertension

Most Recent Events

  • 08 Aug 2002 Discontinued - Preclinical for Hypertension in USA (unspecified route)
  • 10 Feb 2000 Preclinical trials in Hypertension in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top